"Introduction and objective: In Colombia, Dipeptidyl-Peptidase IV (DPP4) inhibitors are recommended as second-
best choice for type 2 diabetes mellitus treatment. However, no evaluation of the accomplishment or impact of this
recommendation
Prescription of DPP4 inhibitors: Indication and effect on glycosylated hemoglobin in a primary care institution of Colombia
Audifarma |
| Tiempo de lectura: Min
- Tema: Endocrinología; Diabetes
- Autores: Juan Daniel Castrillon-Spitia, Valentina Buriticá-Vega, Melissa Hiromi Emura-Vélez, María Camila Rodríguez-Escobar, Mario Andrés Quintana-Duque, Jorge Enrique Machado-Alba
- Idiomas: Inglés
- Palabras clave: Diabetes mellitus; Dipeptidyl-peptidase IV Inhibitors; Hypoglycemic agents; Glycated hemoglobin A; Prescriptions; Guideline adherence.
"Castrillón-Spitia JD, Buriticá-Vega V, Emura-Vélez MH, Rodríguez-Escobar MC, Quintana-Duque MA, Machado-Alba JE. Prescription of DPP4 inhibitors: indication and effect on glycosylated hemoglobin in a primary care institution of Colombia. Salud UIS. 54: e Enlace: https://doi.org/10.18273/saluduis.54.e:22006
